Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000454

Options or other derivatives

  • SVP and CFO acquired 9,520 shares (grant or award)
  • SVP and CFO returned 22,193 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Lamothe Jeffrey G. · SVP and CFO

Table II: Derivative

9 lines
Date Transaction Shares Owned after D/I
2020-07-27 Returned to the company : show line 1 in the form Stock Option (right to buy) −2,695 0 D
2020-07-27 Returned to the company : show line 2 in the form Stock Option (right to buy) −1,928 0 D
2020-07-27 Returned to the company : show line 3 in the form Stock Option (right to buy) −3,128 0 D
2020-07-27 Returned to the company : show line 4 in the form Stock Option (right to buy) −2,407 0 D
2020-07-27 Returned to the company : show line 5 in the form Stock Option (right to buy) −2,407 0 D
2020-07-27 Returned to the company : show line 6 in the form Stock Option (right to buy) −4,814 0 D
2020-07-27 Returned to the company : show line 7 in the form Stock Option (right to buy) −4,814 0 D
2020-07-27 Grant or award : show line 8 in the form Stock Option (right to buy) +7,380 7,380 D
2020-07-27 Grant or award : show line 9 in the form Stock Option (right to buy) +2,140 2,140 D
Loading xslF345X03/lamothe.xml…